Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
In
this section, we provide information about the market for our common equity, the number of holders of our common stock, our dividend
practices, and our repurchases of equity securities. In addition, we provide disclosures regarding our equity compensation plans and
our policies and practices for granting stock options and stock appreciation rights, including awards made in close proximity to the
release of material nonpublic information, as required under recently adopted SEC rules.
Market
Information
Our
common stock is listed on the Nasdaq Capital Market under the symbol “SBFM”. As of April 2, 2026, we had 4,905,945 shares
of our common stock issued and outstanding. We also have tradeable warrants exercisable to purchase shares of our common stock listed
on the Nasdaq Capital Market under the symbol “SBFMW.” As of April 2, 2026, we had 482 tradeable warrants outstanding exercisable
at $220.00 per warrant.
Holders
As
of April 2, 2026, there were approximately 117 holders of record of our common stock. The total number of beneficial owners exceeds holders
of record due to Street-Name holdings.
Dividend
Policy
We
have not paid any dividends since our incorporation and do not anticipate paying any dividends in the foreseeable future. At present,
our policy is to retain earnings, if any, to develop and market our products. Our payment of dividends in the future will depend upon,
among other factors, our earnings, capital requirements, and operating financial conditions.
Repurchases of Equity Securities
We
did not repurchase any shares of our common stock during the three months ended December 31, 2025. We currently do not have a Rule 10b5-1
plan or other repurchase arrangements in place.
20
Equity Compensation Plan Information
The following table sets forth information regarding
our equity compensation plans as of December 31, 2025:
Plan Category
Number of Securities
to be Issued
Upon Exercise
of Outstanding
Options, Warrants
and Rights
Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
Equity compensation plans approved by security holders*
–
–
683,000
Equity compensation plans not approved by security holders
–
–
–
*Represents our 2023 Equity Incentive Plan as amended
on December 11, 2025 at the Company’s 2025 Annual General Meeting of the shareholders.
Option
and SAR Grant Timing in Relation to MNPI Releases
We
have established policies and practices governing the timing and administration of equity awards, including stock options and stock appreciation
rights (“SARs”). We may grant equity awards pursuant to our 2023 Equity Incentive Plan, as approved by the Compensation Committee,
the Board of Directors at regularly scheduled meetings or by unanimous written consent. We do not coordinate the timing of option or
SAR grants with the release of material non-public information (“MNPI”), nor do we time the public disclosure of MNPI for
the purpose of affecting the value of executive compensation. We have not granted any such awards to date.
We
have not granted stock options or SARs to any executive officer in periods proximate to the release of MNPI, as defined in Item 402(x)
of Regulation S-K. Accordingly, no tabular disclosure under Item 402(x)(2) is required for the fiscal years ended December 31, 2024 and
2025. If we were to grant options or SARs in such circumstances in the future, we would provide the required tabular disclosure in accordance
with SEC rules.
ITEM 6. [RESERVED]
21